Potential interactions between antineoplastic agents and medicines used to treat Covid-19.

Mario Jorge Sobreira da SilvaClaudia Garcia Serpa Osorio-de-CastroRafael Duarte PaesChristopher Lucas NegreteElizangela EugênioElaine Lazzaroni MoraesAnnemeri Livinalli

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

Covid-19 is a recent disease and pharmacological interventions are undergoing constant modification. This study identified a considerable number of potential drug-drug interactions. In view of the vulnerability of patients with cancer, it is vital that health professionals carefully assess the risks and benefits of drug combinations.

Keyphrases

coronavirus disease
sars cov
human health
climate change
physical activity
risk assessment
drug induced